← All Omeros CORP filings

Omeros CORP DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
OMER
Omeros CORP
DEF: Omeros Corporation Schedules 2026 Annual Meeting
Omeros Corporation announces its 2026 Annual Meeting of Shareholders, to be held virtually on June 18, 2026, with key proposals including director elections and executive compensation.
NASDAQ
OMER
Omeros CORP
DEF: Omeros Corporation Schedules 2025 Annual Shareholder Meeting, Highlights 2024 Clinical and Financial Progress
Omeros Corporation announced its 2025 Annual Meeting of Shareholders, detailing significant 2024 advancements in its clinical pipeline, including narsoplimab and zaltenibart, alongside strategic financial maneuvers to strengthen its balance sheet.
NASDAQ
OMER
Omeros CORP
DEF 14A: Omeros Corporation Announces Details for 2024 Annual Shareholder Meeting
Omeros Corporation will hold its 2024 Annual Meeting of Shareholders virtually on June 6, 2024, to vote on director elections, executive compensation, and the ratification of its accounting firm.